Clinigence Holdings Inc CLNH
Morningstar’s Analysis
1-Star Price
PREMIUM
5-Star Price
PREMIUM
Economic Moat
PREMIUM
There is no one analyst in which a Quantitative Star Rating and Fair Value Estimate is attributed to; however, Mr. Lee Davidson, Head of Quantitative Research for Morningstar, Inc., is responsible for overseeing the methodology that supports the quantitative fair value. As an employee of Morningstar, Inc., Mr. Davidson is guided by Morningstar, Inc.'s Code of Ethics and Personal Securities Trading Policy in carrying out his responsibilities. For information regarding Conflicts of Interests, click here .
Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.
Company Profile
Clinigence Holdings Inc is a medical technology company. It is focused on the expansion of medical technology business HealthDatix. HealthDatix is an end to end Software-as-a-Service solution managing reports, and analyzing critical data, that enables healthcare organizations to deliver positive patient outcomes. It offers cloud service for healthcare providers to conduct the Medicare Annual Wellness Visit program to their Medicare patients providing the patient with a personalized preventive plan and physician reports.
St. Petersburg, FL, 33701